Get the Stockscreener App
1.65
1.20%
-0.02
Nyxoah Sa stock is traded at $1.65, with a volume of 102.23K.
It is down -1.20% in the last 24 hours and down -44.63% over the past month.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
See More
Previous Close:
$1.67
Open:
$1.71
24h Volume:
102.23K
Relative Volume:
0.39
Market Cap:
$164.88M
Revenue:
$17.85M
Net Income/Loss:
$-96.93M
P/E Ratio:
-0.6671
EPS:
-2.4735
Net Cash Flow:
$-88.29M
1W Performance:
+5.10%
1M Performance:
-44.63%
6M Performance:
-65.26%
1Y Performance:
-77.91%
1-Day Range:
$1.61
$1.71
1-Week Range:
$1.53
$1.71
52-Week Range:
$1.26
$8.5878
Nyxoah Sa Stock (NYXH) Company Profile
Name
Nyxoah Sa
Sector
Industry
Phone
-
Address
-
Compare NYXH vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
1.65 | 166.88M | 17.85M | -96.93M | -88.29M | -2.4735 |
ISRG
Intuitive Surgical Inc
|
405.97 | 143.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
155.19 | 42.96B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.61 | 32.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.61 | 33.07B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
198.43 | 29.05B | 5.54B | 1.52B | 1.74B | 10.37 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-21-22 | Initiated | Oppenheimer | Outperform |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Dec-21-21 | Resumed | Cantor Fitzgerald | Overweight |
| Jul-28-21 | Initiated | Cantor Fitzgerald | Overweight |
View All
Nyxoah Sa Stock (NYXH) Latest News
Enterprise value to revenue forward of Nyxoah SA – EURONEXT:NYXH - TradingView
Nyxoah sees Orin Hirchman cross 10% voting rights threshold, Resmed drops below 3%. - Pluang
Nyxoah gets two ownership notices: AIGH at 14.55%, Resmed at 1.95% - Stock Titan
Price to earnings forward of Nyxoah SA – LSX:A2QCWK - TradingView
Price to sales forward of Nyxoah SA – LSX:A2QCWK - TradingView
Nyxoah SA Actuals & Estimates (EURONEXT:NYXH) - TradingView
NYXH Forecast — Price Target — Prediction for 2027 - TradingView
Nyxoah to Host Investor Day in New York on July 8, 2026 - Sahm
Nyxoah SA (NYXH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Nyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Analyst Cuts And Capital Concerns - Yahoo Finance
Form 6K Nyxoah For: 23 June By Investing.com - Investing.com Nigeria
Nyxoah (NASDAQ: NYXH) adds $15M EIB debt and details major holders - Stock Titan
Nyxoah SA (NYXH) may report negative earnings: Know the trend ahead of next week's release - MSN
symbol__ Stock Quote Price and Forecast - CNN
Form 13G NYXOAH SA For: 22 June By Investing.com - Investing.com Australia
Form 13G NYXOAH SA For: 22 June - Investing.com UK
AIGH entities and Orin Hirschman report 14.5% stake in NYXOAH (NASDAQ: NYXH) - Stock Titan
Nyxoah SA (NYXH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Stifel Maintains Nyxoah SA(NYXH.US) With Hold Rating, Maintains Target Price $3 - Moomoo
Nyxoah (NYXH) 44th Annual J.P. Morgan Healthcare Conference Summary - Quartr
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 9, 2026 - GlobeNewswire
Nyxoah seeks shareholder approval to renew capital authority July 9 - Stock Titan
Nyxoah SA (NYXH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nyxoah SA (NYXH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nyxoah SA (NYXH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nyxoah SA (NYXH) Institutional Confidence - TradingKey
Nyxoah Receives $15 Million From European Investment Bank - Moomoo
Publication relating to transparency notifications - Yahoo Finance UK
Nyxoah Receives $15 Million from the European Investment Bank - Yahoo Finance UK
Stifel cuts Nyxoah stock price target to $3 on capital concerns By Investing.com - Investing.com South Africa
Stifel cuts Nyxoah stock price target to $3 on capital concerns - Investing.com
Nyxoah SA (NYXH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nyxoah SA (NYXH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nyxoah SA (NYXH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
United StatesMintz Advises On Nyxoah’s $95 Million Public Offering - Mondaq
Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology - GlobeNewswire
Nyxoah Updates Capital Structure After Major Share Issuance - The Globe and Mail
Nyxoah (NASDAQ: NYXH) adds 55,232,558 new shares after US offering - Stock Titan
Cochlear (NYXH) reports 5.91% beneficial ownership in Nyxoah - Stock Titan
Nyxoah closes underwritten public offering - Medical Buyer
Nyxoah Raises $95 Million Through Public Stock Offering in the United States - Idéal Investisseur
Nyxoah Finalizes Capital Raise - marketscreener.com
Nyxoah Set to Receive $110 Million in New Capital Following Equity Financing, Loan - marketscreener.com
Nyxoah issues 55.2M new shares after US public offering, raising total voting shares to nearly 100M. - Pluang
$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch - Sahm
Nyxoah issues 55.2M new shares, boosting total voting rights to nearly 100M. - Pluang
Nyxoah raises $110 million to fund U.S. expansion of sleep apnea device By Investing.com - Investing.com South Africa
Information on the total number of voting rights and shares - GlobeNewswire
Nyxoah raises $110 million to fund U.S. expansion of sleep apnea device - Investing.com
Nyxoah Sa Stock (NYXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.09%
0.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):